Search
for
Sort by
Research 571–600 of 1000+
- Alopecia Areata Update
- Safety of testosterone treatment in postmenopausal women
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Insulin Resistance and Skin Diseases
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- The role of nuclear hormone receptors in cutaneous wound repair
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- The control of hair growth: An overview
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- ACNE
- Elevated Free Testosterone Levels in Women With Acne
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Female type of adult acne: Physiological and psychological considerations and management
- Mood disorders and quality of life in polycystic ovary syndrome
- Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Hormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women?
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Interventions for female pattern hair loss
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Polycystic ovary syndrome: A review for dermatologists
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications